eKare Image

COVID-19 has underscored the value of businesses embracing digital technologies in the healthcare space — from telehealth and remote patient monitoring to artificial intelligence (AI) for predictive analytics and diagnostic insights.

During the pandemic — especially before the widespread rollout of vaccines — many vulnerable populations, such as healthcare workers and the elderly, likewise turned to remote medical care whenever possible to avoid potentially contracting or spreading the coronavirus. Digitization was the undercurrent of this new reality. At the nexus of these digitization and remote care trends is a company long aware of the challenges and opportunities in health tech: eKare, Inc.

eKare describes itself as “an advanced wound imaging and data analytics company.” The Fairfax County-based software-as-a-service company was founded in 2014, borne out of a collaborative project between three biomedical engineers. Patrick Cheng, the company’s co-founder and CEO, has spent the last several years building up his company in the healthcare technology space.

Tackling Wound Medicine Through a Smartphone

In the early 2010s, Cheng and his future co-founders, Kyle Wu and Özgür Güler, were based at the Children’s National Medical Center in Washington, D.C., performing needs assessments of healthcare patients and practitioners, and began noticing ways that new technologies were underutilized in addressing wound care challenges. The colleagues were experimenting with using cellphones to help patients manage post-surgery fluid intake and outtake, and that research led them to found eKare in 2014.

eKare, Inc., Fairfax County

eKare, Inc., Fairfax County

As they refined the technology, though, they realized its potential in the wound care space could be even greater. That’s when Cheng, with a passion for business health tech, Wu, a biomedical engineer and physician, and Güler, an imaging scientist, united to launch eKare.

“Fundamentally, we wanted to advance the wound imaging and diagnostics by bringing cutting-edge technology to the familiar smartphone,” Cheng said. “The technology has enabled providers to capture and assess complex wounds by just point and shoot. The higher-quality cameras in today’s smartphones open up the possibility for unprecedented levels of clear, 3D imaging, and the platform enabled providers to streamline and standardize clinical workflow and documentation.”

Cheng, Wu, and Güler built inSight®, a 3D digital wound management platform now used by thousands of organizations worldwide, from large Fortune 500 conglomerates to small emergency rooms and medical clinics. But the company’s journey to global market reach was filled with challenges — and finding the right partners and platforms through which to grow the business.

Scaling Up Internationally

When eKare first launched, there was great excitement about its technology. Medical professionals relying on expensive equipment to image patients’ wounds were presented the option of using a smartphone. Imaging could be done more quickly, at lower cost, and with highly accurate measurements.

inSight was only the beginning of eKare’s journey; other challenges in marketing, pricing, and expansion lay ahead. That went doubly so in international markets that did not yet see the need for the product — or that were a challenge for a new U.S. firm to reach.

In addition to its own outreach, Cheng said, working with VEDP’s International Trade division helped eKare reach those global business opportunities. The company originally leveraged multiple grant programs through VEDP to assist with early-stage fundraising and took advantage of VEDP’s market research capabilities, particularly as eKare sought to understand the global market landscape.

All of this was critical because many factors are key for healthcare technology startups — reimbursement arrangements within clinics, integrating a new technology into a medical practice’s IT environment, and clearly marketing how a technology will substantively improve care. eKare increasingly needed to navigate new frontiers beyond research and development.

Now, eKare has partnerships with a number of organizations in Singapore and Hong Kong. Its largest international markets are the United Kingdom and the European Union, and it has a Dutch subsidiary, eKare Europe.

Finding the Right Partners

Marketing eKare’s technology internationally was a big step in the company’s journey. Finding the right partners has also been crucial.

“Every specialty is like its own mini-industry within healthcare. They have their own associations; they have their own groups of people that they talk to,” Cheng said. “It’s very important for us when we go into the space to find the companies that are good potential partners. If we don’t interact with the right type of company, even if they’re in the healthcare industry, it might not be a good fit.”

VEDP helped arrange meetings with other companies, as well as participation in specialized health tech conferences and trade shows. Even during the COVID-19 pandemic, eKare participated in a virtual trade mission to South Korea and Japan, an opportunity VEDP helped facilitate. As a result, Cheng said, eKare was able to connect with a Japanese company that works in a similar area — and that may potentially serve as a future partner for the company. More recently, eKare was selected to participate in VEDP’s Virginia Leaders in Export Trade (VALET) program.

eKare

eKare's inSight wound management platform leverages improvements to smartphone cameras to enhance wound imaging and treatment.

eKare's international marketing and public relations efforts include securing coverage in publications like Chilean newspaper 'El Mercurio'

eKare's international marketing and public relations efforts include securing coverage in publications like Chilean newspaper 'El Mercurio'

“They provide many helpful resources for a company like us in our current stage,” Cheng said, “like with managing our workforce, managing taxation issues across multiple countries, and other issues."

The Future of Advanced Wound Imaging and Med-Tech

Going forward, eKare’s vision goes far beyond that of smartphone imaging software. “Now that we have a very complex platform, our vision moving forward is that we have a huge repository of very good data about these conditions,” Cheng said. “We want to leverage that data to help providers or a patient improve outcomes.”

On top of that, improvements to the smartphone technology could enhance imaging even further and identify things not visible to the human eye. Bacteria could be imaged through fluorescence scanning, or eKare could develop its technology to assess how much oxygen might be flowing to the skin based on smartphone imaging.

Beyond that, Cheng describes his vision as three-fold: “One, a point- of-care mobile device digital solution that everyone has in their hands to help collect data. The second piece is really enhancing that ability to see things beyond the visible, to see the physiological parameters that aren’t usually visible for normal humans. And lastly, bringing all this data together to create smart, intelligent AI solutions to help people improve care.”

Suggested Reading

Life Sciences: A Faster, Safer Way to Develop Drugs

Life Sciences & Quantum: A Faster, Safer Way to Develop Drugs

Third Quarter 2023

Recent moves from computer titans such as Google and IBM and pharmaceutical giants like Roche and Merck & Co., Inc. suggest drug research might prove to be among quantum computing’s first killer apps. The reasons? Time and money.

Read More
Embody - Teaser Only

Positioned to Thrive

First Quarter 2022

Medical device manufacturer Embody sets stage for international growth. 

Read More

Podcasts

April Wade, Executive Director, Virginia Nuclear Energy Consortium

Nuclear’s Role in the Future of Clean Energy: A Conversation With April Wade

January 4, 2024

Executive Director, Virginia Nuclear Energy Consortium

Bob Blue, Chair, President and CEO, Dominion Energy, Inc.

Charting a Cleaner Energy Future for Virginia: A Conversation With Bob Blue

January 4, 2024

Chair, President, and CEO, Dominion Energy, Inc.

View All Podcasts